A combination of three different drugs that block the HER-2 receptor, a critical cellular growth signal for some breast cancers, eradicated aggressive breast tumors in mice and could point the way toward developing better treatments in patients, said researchers from the Breast Center at Baylor College of Medicine in a report that appears in the Journal of the National Cancer Institute.
The New England Journal of Medicine is publishing results from two Phase III studies of Merck’s cervical cancer vaccine, GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine].
Consumer Reports ranked “The Volumetrics Eating Plan,” based on research by Barbara Rolls, the holder of the Guthrie Chair of Nutrition at Penn State, as the top-rated diet in its new June issue, released today (May 8).
The Honourable Tony Clement, Minister of Health, congratulated three recipients of the Award of Excellence in Nursing for nurses working in First Nations and Inuit communities. The ceremony, held during National Nursing Week, took place at the Government Conference Centre in Ottawa.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Eli Lilly and Co’s cancer treatment Gemzar? (Gemcitabine) for injection, 200 mg base/vial.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Applications (ANDA) to market its generic versions of Abbott’s antibiotic Omnicef? (Cefdinir) Capsules, 300 mg, and for Oral Suspension, 125 mg/5 mL and 250 mg/5 mL. Teva has commenced shipment of these products.
Roche announced that the U.S. Food & Drug Administration (FDA) has approved its new HIV-1 test for diagnostic use in the United States. The highly accurate Cobas AmpliPrep/Cobas TaqMan HIV-1 Test is the first fully automated HIV-1 diagnostic tool using real-time PCR technology in the US.
The U.S. Food and Drug Administration’s (FDA) Office of Criminal Investigations (OCI) announced that The Purdue Frederick Company, Inc. has agreed to pay more than $600 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin, a powerful prescription pain reliever that the company produces.
The Food and Drug Administration (FDA) is advising consumers not to purchase or use “True Man” or “Energy Max” products promoted and sold as dietary supplements throughout the United States. Both products — touted as sexual enhancement products and as treatments for erectile dysfunction (ED) — are illegal drug products that contain potentially harmful, undeclared ingredients.
The Hong Kong Centre for Food Safety appeals to the trade to stop selling a batch of MaraNatha brand Organic Raw Sesame Tahini, No Salt, suspected to be contaminated with salmonella. People who have purchased the product are warned not eat it.